Find a GammaTile

treatment center near you

Look for the Centers of EXCELLENCE icon. This designation recognizes an institution’s exceptional expertise in the GammaTile procedure.*

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center is a GammaTile Center of Excellence. This designation recognizes an institution’s exceptional expertise in the GammaTile procedure.
  • Center of Excellence
  • Center of Excellence
  • Clinical Study Site

Memorial Sloan Kettering Cancer Center

About Memorial Sloan Kettering Cancer Center

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.

View this Institution’s Socials
  • About the GammaTile Center of Excellence Program

    Treatment centers designated as a GammaTile Center of Excellence (COE) have demonstrated an exceptional level of clinical expertise and experience in the GammaTile procedure. To achieve this COE designation, doctors and their institutions must meet annual criteria that establishes their contributions to advancements in therapy, commitment to improving patient outcomes, and dedication to supporting patient education.

Participating Physicians
  • Nelson Moss, MD, Neurosurgeon, Co-Director Multi-Disciplinary Brain Metastases Program
  • Brandon Imber, MD, MA, Radiation Oncologist, Early Drug Development Specialist
  • Center of Excellence
MKT-489-02